Sulabh Nayyar, Director

Saksham Sabharwal, Head of Operations

The pharmaceutical market in India has witnessed remarkable development and growth, establishing itself as one of the largest sectors in the country. With a steady expansion, the domestic pharmaceutical market is projected to reach $130 billion by 2030, driven by several key factors. The increasing population, expanding middle class, and improved healthcare access have contributed to the growth of the domestic pharmaceutical market. Additionally, rising incomes and lifestyle changes have led to increased healthcare spending, further fueling market growth. India's reputation as the ‘Pharmacy of the World’ also plays a significant role, as the cost-effectiveness and quality of its generic drugs have made them popular globally, resulting in increased exports and revenue.

A leader in the pharmaceutical industry, Sidhaant Life Sciences is playing a vital role in empowering the healthcare sector in Africa. With a focus on providing affordable generics to the local population with a focus on Biotechnology products and Biosimilars, the company understands the unique healthcare needs of these vulnerable populations. The firm aims to provide comprehensive and affordable solutions to address these needs. Sidhaant Life Sciences envisions becoming one of the largest suppliers of medical kits for various ailments for women and infants, especially during the period of maternity. By expanding its product offerings, the firm strives to ensure access to affordable medications, reducing the burden on healthcare systems. Committed to affordability and accessibility, Sidhaant Life Sciences continually explores new opportunities and innovates within its product range. Its dedication to making a positive impact on the health and well-being of individuals across the African continent underscores its mission. Through its efforts, the firm contributes to the growth and development of the healthcare sector in Africa, improving the lives of millions of people in the process.

Positioning & Market Presence in the Pharmaceutical Industry

In this thriving market, Sidhaant Life Sciences has positioned itself as a prominent player. The company has established a strong market presence and a solid reputation by offering quality products at affordable prices. With an extensive catalog of over 800+ products, including biosimilars, oncology drugs, and dialysis products, Siddhant Life Sciences caters to the diverse needs of customers across the African continent. What sets the company apart is its adherence to EU GMP standards and similar standards, ensuring the delivery of high-quality and safe medications to customers. Sidhaant Life Sciences also prides itself on its extensive market coverage, with over 300 registrations across Africa, enabling the company to effectively serve customers in different regions. “We understand the challenges involved in delivering medicines to these regions and have implemented measures to mitigate risks and ensure timely delivery”, says Sulabh Nayyar, Director, Sidhaant Life Sciences.

Unique Approach to Quality & Customer Satisfaction

The flagship products and services offered by Sidhaant Life Sciences encompass a wide range of pharmaceutical solutions. The company specializes in biosimilars like bevacizumab and ranibizumab, as well as oncology and dialysis products such as heparin, enoxaparin, and iron sucrose. Sidhaant Life Sciences' comprehensive product range, combined with its strict adherence to quality standards and customer-centric approach, sets it apart from competitors in the market. Moreover, the company's approach to ensuring product quality and service effectiveness is characterized by its adherence to international standards, rigorous supplier selection and auditing, bulk purchasing strategies, in-house and third-party testing, and stringent standard operating procedures. "By following these unique approaches we ensure that our products meet the highest standards of quality and efficacy. Our commitment to stringent quality control and adherence to international guidelines sets us apart and instills confidence in our customers”, shares Saksham Sabharwal, Head of Operations, Sidhaant Life Sciences.

Journey of Success

Since its inception in 2009, Sidhaant Life Sciences has experienced a remarkable journey of growth and success. The company has witnessed exponential growth in terms of client acquisition and geographical expansion. By offering high-quality products and services, Sidhaant Life Sciences has built a strong customer base and expanded its operations to cover 19 countries across Africa. The company has also pioneered various initiatives, such as introducing oncology products and generic formulations, contributing to improved cancer treatment accessibility and better healthcare access in its regions. Looking ahead, Sidhaant Life Sciences aims to expand its geographical reach, mainly focusing on key customers in Africa. The company also plans to introduce innovative products and services, including biosimilars, plasma-derived products, and advanced anesthesia products. By continuously striving for affordability, accessibility, and innovation, Sidhaant Life Sciences aims to positively impact healthcare in Africa and become a leading supplier of generic formulations on the continent.